LIGHTXDISPLAY Trademark

Trademark Overview


On Monday, June 3, 2024, a trademark application was filed for LIGHTXDISPLAY with the United States Patent and Trademark Office. The USPTO has given the LIGHTXDISPLAY trademark a serial number of 98582198. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 25, 2025. This trademark is owned by WUXI BIOLOGICS IRELAND LIMITED. The LIGHTXDISPLAY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product development for others; Consulting services in the field of technological product development; Scientific research and development; Research and development of new products; Scientific laboratory services; Biochemical research; Biochemical research and analysis; Research and development in the field of antibodies; Development of pharmaceutical preparations and medicines; Research and development of drugs; Biomedical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals
lightxdisplay

General Information


Serial Number98582198
Word MarkLIGHTXDISPLAY
Filing DateMonday, June 3, 2024
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, January 28, 2025

Trademark Statements


Pseudo MarkLIGHT X DISPLAY
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesProduct development for others; Consulting services in the field of technological product development; Scientific research and development; Research and development of new products; Scientific laboratory services; Biochemical research; Biochemical research and analysis; Research and development in the field of antibodies; Development of pharmaceutical preparations and medicines; Research and development of drugs; Biomedical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 3, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Party NameWUXI BIOLOGICS IRELAND LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDUNDALK, CO LOUTH A91X56F
IE

Trademark Events


Event DateEvent Description
Monday, June 3, 2024NEW APPLICATION ENTERED
Monday, December 16, 2024ASSIGNED TO EXAMINER
Thursday, December 19, 2024NON-FINAL ACTION WRITTEN
Thursday, December 19, 2024NON-FINAL ACTION E-MAILED
Sunday, December 15, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 7, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 7, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 22, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 28, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 28, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 25, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 7, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED